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documentation of the neurodevelopmental and cognitive out-
come of these patients.
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Reply to the Editor:
We appreciate the comments of Rodriguez and colleagues.
Although the patient was not actively cooled, a low ambient
temperature allowed the patient’s body temperature to initial-
ly drift to around 33°C, necessitating active rewarming at the
end of the operation. It is known that moderate to mild (26°C-
35°C) hypoperfusion can attenuate the so-called excitotoxic
cascade associated with cerebral hypoperfusion. Similarly,
there is a fairly steep exponential fall in the cerebral meta-
bolic rate for oxygen, with temperatures ranging from nor-
mothermia to 35°C. These facts, taken together with the short
superior vena cava clamp time, should minimize the risk of
neurologic damage.
We will endeavor to supplement future attempts at per-
forming the bidirectional Glenn procedure without bypass
with near-infrared spectroscopy of transcranial Doppler
assessment of cerebral blood flow. In addition, we agree with
the authors that demonstrating the safety of this operation
will need detailed assessment of the patients by neurologic
and psychometric testing.
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Preimplantation retrograde pneumoplegia in clinical
lung transplantation
To the Editor:
I read with interest the article by Venuta and associates1
concerning 14 consecutive patients who underwent lung
transplantation. The first patients, group I, had antegrade
pneumoplegia with Euro-Collins solution preceded by pul-
monary arterial flushing with alprostadil (prostaglandin E1).
In group II, additional retrograde flushing was given via the
pulmonary veins just before implantation. The authors con-
cluded that retrograde flushing is not detrimental and helps to
improve early graft function. The chest x-ray score was sig-
nificantly better in group II, intubation time was less, and the
ratio of arterial PO2 to inspired oxygen fraction was
improved, although the differences did not reach statistical
significance.
My colleagues and I2 were the first group to use retrograde
pneumoplegia in clinical transplantation. However, we did
not use antegrade pneumoplegia in those patients, nor did we
use alprostadil. The retrograde pneumoplegic solution was
given via the left atrium and the flush solution was vented
through an incision in the pulmonary artery. This was done
immediately after the aorta was crossclamped and cardiople-
gia established. The lung almost seemed to light up as the ret-
rograde infusion started. Retrograde pneumoplegia was asso-
ciated with excellent oxygenation, which remains the most
sensitive indicator of the adequacy of lung preservation, as
well as the lack of any reimplantation response postopera-
tively, a finding also shown by the current study. What
Venuta’s study really demonstrates is that retrograde pneu-
moplegia may confer additional benefits to lung preservation
compared with those of antegrade pneumoplegia alone.
Two criticisms can be leveled at this study. First, retrograde
pneumoplegia was given after harvesting of the donor lung,
not at the time of the harvesting. This point has already been
addressed, and the current practice of the group is to give the
retrograde perfusion solution immediately after the antegrade
perfusion is finished. The second criticism is that pneumo-
plegic solution was given individually into each pulmonary
vein. This method is at variance with our technique, in which
the pneumoplegic solution was given into the left atrium and
therefore had a uniform distribution through both lungs,
something that cannot be guaranteed if individual veins are
perfused separately.
I do congratulate Venuta and his colleagues for highlight-
ing the potential advantage of retrograde pulmonary perfu-
sion in clinical lung transplantation.
Mazin A. I. Sarsam, FRCS
Cardiac Surgery
The Royal Victoria Hospital
Grosvenor Rd
Belfast BT12 6BA, Northern Ireland
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